Symbols / CERO Stock $0.03 -2.86% CERo Therapeutics Holdings, Inc.
CERO (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Ratings
Current target
$0.03
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-18 | down | D. Boral Capital | Buy → Hold | — |
| 2025-10-30 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-10-22 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-10-13 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-09-23 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-09-09 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-09-05 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-08-04 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-06-24 | main | D. Boral Capital | Buy → Buy | $30 |
| 2025-06-23 | up | D. Boral Capital | Hold → Buy | $30 |
| 2025-05-30 | down | D. Boral Capital | Buy → Hold | — |
| 2025-05-19 | init | Maxim Group | — → Buy | $3 |
| 2025-04-25 | main | D. Boral Capital | Buy → Buy | $11 |
| 2025-04-23 | main | D. Boral Capital | Buy → Buy | $11 |
| 2025-04-22 | init | D. Boral Capital | — → Buy | $11 |
- Cero Therapeutics registers up to 12.5M shares for potential sale under equity agreement with Keystone - MSN Sun, 26 Apr 2026 15
- CERO Therapeutics (CERO) director receives stock options for 1.82M shares - Stock Titan ue, 21 Apr 2026 23
- CERo Therapeutics Completes First Tranche of $7 Million Financing to Support Clinical Development and Nasdaq Compliance - Quiver Quantitative ue, 21 Oct 2025 07
- Cero Therapeutics enters new stock purchase agreement for up to $14.6 million - Investing.com ue, 02 Dec 2025 08
- CERO SEC Filings - CERo Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan hu, 16 Apr 2026 12
- If You Invested $1,000 in CERo Therapeutics (CERO) - Stock Titan Sun, 22 Mar 2026 18
- CERO Therapeutics (CERO) director files Form 3 ownership - Stock Titan ue, 21 Apr 2026 23
- CERo expands blood cancer trial after sixth patient dose - Stock Titan ue, 14 Apr 2026 07
- Leukemia trial patient goes 61 days without platelet transfusion - Stock Titan Wed, 07 Jan 2026 08
- MDS patient in CERo trial goes 2 months without transfusions - Stock Titan Wed, 11 Mar 2026 07
- [424B3] CERO THERAPEUTICS HOLDINGS, INC. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan ue, 14 Apr 2026 20
- Ex-SCYNEXIS CFO who raised $300M joins CERo cancer board - Stock Titan ue, 17 Feb 2026 08
- After early safety data, CERo expands cell therapy study to MDS, MF - Stock Titan Mon, 30 Mar 2026 07
- Trial cell therapy spares high-risk patient two months of platelet transfusions - Stock Titan Wed, 04 Feb 2026 08
- CERo Therapeutics (NASDAQ: CERO) denied over $2.5M equity rule; suspended Oct. 31 - Stock Titan Wed, 29 Oct 2025 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
19.33
+151.81%
|
7.68
-35.89%
|
11.97
+3.06%
|
11.62
|
| Research And Development |
|
10.38
+96.31%
|
5.29
-46.28%
|
9.85
+7.76%
|
9.14
|
| Selling General And Administration |
|
8.94
+274.81%
|
2.39
+12.27%
|
2.13
-14.27%
|
2.48
|
| General And Administrative Expense |
|
8.94
+274.81%
|
2.39
+12.27%
|
2.13
-14.27%
|
2.48
|
| Salaries And Wages |
|
0.86
|
—
|
—
|
—
|
| Other Gand A |
|
8.08
+238.63%
|
2.39
+12.27%
|
2.13
-14.27%
|
2.48
|
| Total Expenses |
|
19.33
+151.81%
|
7.68
-35.89%
|
11.97
+3.06%
|
11.62
|
| Operating Income |
|
-19.33
-151.81%
|
-7.68
+35.89%
|
-11.97
-3.06%
|
-11.62
|
| Total Operating Income As Reported |
|
-18.46
-140.56%
|
-7.68
+35.89%
|
-11.97
-3.06%
|
-11.62
|
| EBITDA |
|
-18.24
-178.15%
|
-6.56
+39.83%
|
-10.90
-0.16%
|
-10.88
|
| Normalized EBITDA |
|
-17.64
-156.81%
|
-6.87
+36.99%
|
-10.90
-0.16%
|
-10.88
|
| Reconciled Depreciation |
|
1.09
-2.79%
|
1.12
+4.14%
|
1.07
+45.87%
|
0.74
|
| EBIT |
|
-19.33
-151.81%
|
-7.68
+35.89%
|
-11.97
-3.06%
|
-11.62
|
| Total Unusual Items |
|
-0.61
-295.73%
|
0.31
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.61
-295.73%
|
0.31
|
—
|
—
|
| Special Income Charges |
|
-0.61
-7533.93%
|
0.01
|
—
|
—
|
| Other Special Charges |
|
—
|
-0.01
|
—
|
—
|
| Write Off |
|
0.61
|
—
|
—
|
—
|
| Net Income |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Pretax Income |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Net Non Operating Interest Income Expense |
|
0.01
-91.60%
|
0.14
-2.66%
|
0.14
-85.60%
|
0.99
|
| Net Interest Income |
|
0.01
-91.60%
|
0.14
-2.66%
|
0.14
-85.60%
|
0.99
|
| Interest Income Non Operating |
|
0.01
-91.60%
|
0.14
-2.66%
|
0.14
-85.60%
|
0.99
|
| Interest Income |
|
0.01
-91.60%
|
0.14
-2.66%
|
0.14
-85.60%
|
0.99
|
| Other Income Expense |
|
-0.61
-344.88%
|
0.25
|
—
|
—
|
| Other Non Operating Income Expenses |
|
0.00
+100.39%
|
-0.06
|
—
|
—
|
| Gain On Sale Of Security |
|
—
|
0.30
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Net Income From Continuing Operation Net Minority Interest |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Net Income From Continuing And Discontinued Operation |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Net Income Continuous Operations |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Normalized Income |
|
-19.31
-154.18%
|
-7.60
+35.76%
|
-11.83
-11.28%
|
-10.63
|
| Net Income Common Stockholders |
|
-95.53
-1210.45%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Otherunder Preferred Stock Dividend |
|
0.08
|
0.00
|
—
|
—
|
| Diluted EPS |
|
—
|
-1,416.55
+45.74%
|
-2,610.71
-11.28%
|
-2,345.98
|
| Basic EPS |
|
—
|
-1,416.55
+45.74%
|
-2,610.71
-11.28%
|
-2,345.98
|
| Basic Average Shares |
|
—
|
0.01
+31.63%
|
0.00
+0.00%
|
0.00
|
| Diluted Average Shares |
|
—
|
0.01
+31.63%
|
0.00
+0.00%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-95.53
-1210.45%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Preferred Stock Dividends |
|
75.52
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
3.64
-41.34%
|
6.21
+21.08%
|
5.13
-54.83%
|
11.35
|
| Current Assets |
|
2.73
-26.38%
|
3.71
+88.53%
|
1.97
-72.16%
|
7.08
|
| Cash Cash Equivalents And Short Term Investments |
|
1.66
-50.03%
|
3.33
+107.78%
|
1.60
-76.52%
|
6.82
|
| Cash And Cash Equivalents |
|
1.66
-50.03%
|
3.33
+107.78%
|
1.60
-76.52%
|
6.82
|
| Cash Financial |
|
1.66
-50.03%
|
3.33
+107.78%
|
1.60
-76.52%
|
6.82
|
| Current Deferred Assets |
|
0.00
-100.00%
|
0.11
|
0.00
|
—
|
| Other Current Assets |
|
1.07
+290.14%
|
0.27
-25.50%
|
0.37
+43.80%
|
0.26
|
| Total Non Current Assets |
|
0.91
-63.62%
|
2.49
-21.02%
|
3.16
-26.14%
|
4.27
|
| Net PPE |
|
0.91
-54.50%
|
1.99
-36.86%
|
3.16
-26.14%
|
4.27
|
| Gross PPE |
|
3.22
-20.00%
|
4.02
-15.29%
|
4.74
-12.16%
|
5.40
|
| Accumulated Depreciation |
|
-2.31
-13.94%
|
-2.03
-27.60%
|
-1.59
-40.87%
|
-1.13
|
| Properties |
|
—
|
—
|
—
|
0.00
|
| Buildings And Improvements |
|
—
|
—
|
—
|
2.85
|
| Machinery Furniture Equipment |
|
0.05
+0.00%
|
0.05
+0.00%
|
0.05
+0.00%
|
0.05
|
| Other Properties |
|
3.17
-20.23%
|
3.97
-15.44%
|
4.70
-12.26%
|
5.35
|
| Non Current Deferred Assets |
|
0.00
-100.00%
|
0.50
|
0.00
|
—
|
| Total Liabilities Net Minority Interest |
|
9.09
+12.17%
|
8.10
-82.83%
|
47.18
+2.09%
|
46.22
|
| Current Liabilities |
|
9.09
+22.77%
|
7.40
+111.07%
|
3.51
+201.31%
|
1.16
|
| Payables And Accrued Expenses |
|
8.20
+30.95%
|
6.26
+258.29%
|
1.75
+270.41%
|
0.47
|
| Payables |
|
8.08
+73.04%
|
4.67
+179.42%
|
1.67
+327.35%
|
0.39
|
| Accounts Payable |
|
7.58
+68.19%
|
4.51
+169.62%
|
1.67
+327.35%
|
0.39
|
| Other Payable |
|
0.34
|
—
|
—
|
—
|
| Dividends Payable |
|
0.09
+0.00%
|
0.09
|
0.00
|
—
|
| Current Accrued Expenses |
|
0.12
-92.68%
|
1.59
+1994.43%
|
0.08
-5.83%
|
0.08
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.17
-30.87%
|
0.24
+255.62%
|
0.07
+247.69%
|
0.02
|
| Total Tax Payable |
|
0.08
+0.00%
|
0.08
|
0.00
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.70
-20.23%
|
0.88
-35.97%
|
1.37
+103.57%
|
0.67
|
| Current Debt |
|
—
|
—
|
0.60
|
—
|
| Current Capital Lease Obligation |
|
0.70
-20.23%
|
0.88
+13.95%
|
0.77
+14.38%
|
0.67
|
| Other Current Liabilities |
|
0.02
+0.00%
|
0.02
-93.79%
|
0.32
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.70
-98.40%
|
43.68
-3.06%
|
45.06
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.70
-55.63%
|
1.58
-32.80%
|
2.34
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.70
-55.63%
|
1.58
-32.80%
|
2.34
|
| Preferred Securities Outside Stock Equity |
|
—
|
0.00
-100.00%
|
42.10
+0.00%
|
42.10
|
| Stockholders Equity |
|
-5.45
-187.48%
|
-1.89
+95.50%
|
-42.06
-20.61%
|
-34.87
|
| Common Stock Equity |
|
-12.71
-150.64%
|
-5.07
+87.94%
|
-42.06
-20.61%
|
-34.87
|
| Capital Stock |
|
7.27
+128.73%
|
3.18
+317645700.00%
|
0.00
-99.89%
|
0.00
|
| Common Stock |
|
0.00
+17483.33%
|
0.00
+1100.00%
|
0.00
-99.89%
|
0.00
|
| Preferred Stock |
|
7.26
+128.67%
|
3.18
|
0.00
|
—
|
| Share Issued |
|
21.10
+15198.44%
|
0.14
+2212.88%
|
0.01
+15.90%
|
0.01
|
| Ordinary Shares Number |
|
21.10
+15198.44%
|
0.14
+2212.88%
|
0.01
+15.90%
|
0.01
|
| Additional Paid In Capital |
|
78.13
+16.36%
|
67.14
+6405.25%
|
1.03
+11.15%
|
0.93
|
| Retained Earnings |
|
-90.84
-28.09%
|
-70.92
-64.58%
|
-43.09
-20.36%
|
-35.80
|
| Total Equity Gross Minority Interest |
|
-5.45
-187.48%
|
-1.89
+95.50%
|
-42.06
-20.61%
|
-34.87
|
| Total Capitalization |
|
-5.45
-187.48%
|
-1.89
+95.50%
|
-42.06
-20.61%
|
-34.87
|
| Working Capital |
|
-6.35
-72.25%
|
-3.69
-139.95%
|
-1.54
-126.00%
|
5.91
|
| Invested Capital |
|
-12.71
-150.64%
|
-5.07
+87.77%
|
-41.46
-18.89%
|
-34.87
|
| Total Debt |
|
0.70
-55.63%
|
1.58
-46.49%
|
2.94
-2.41%
|
3.02
|
| Capital Lease Obligations |
|
0.70
-55.63%
|
1.58
-32.80%
|
2.34
-22.29%
|
3.02
|
| Net Tangible Assets |
|
-5.45
-187.48%
|
-1.89
+95.50%
|
-42.06
-20.61%
|
-34.87
|
| Tangible Book Value |
|
-12.71
-150.64%
|
-5.07
+87.94%
|
-42.06
-20.61%
|
-34.87
|
| Current Notes Payable |
|
—
|
0.00
-100.00%
|
0.60
|
—
|
| Derivative Product Liabilities |
|
—
|
—
|
—
|
0.61
|
| Interest Payable |
|
—
|
0.00
-100.00%
|
0.03
|
—
|
| Other Equity Interest |
|
—
|
-1.30
|
—
|
—
|
| Preferred Stock Equity |
|
7.26
+128.67%
|
3.18
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-16.08
-177.73%
|
-5.79
+50.55%
|
-11.71
-16.00%
|
-10.09
|
| Cash Flow From Continuing Operating Activities |
|
-16.08
-177.73%
|
-5.79
+50.55%
|
-11.71
-16.00%
|
-10.09
|
| Net Income From Continuing Operations |
|
-19.92
-173.27%
|
-7.29
+38.38%
|
-11.83
-11.28%
|
-10.63
|
| Depreciation Amortization Depletion |
|
1.09
-2.79%
|
1.12
+4.14%
|
1.07
+45.87%
|
0.74
|
| Depreciation |
|
1.09
-2.79%
|
1.12
+4.14%
|
1.07
+45.87%
|
0.74
|
| Depreciation And Amortization |
|
1.09
-2.79%
|
1.12
+4.14%
|
1.07
+45.87%
|
0.74
|
| Other Non Cash Items |
|
—
|
0.04
|
—
|
—
|
| Stock Based Compensation |
|
1.96
+1922.38%
|
0.10
-74.57%
|
0.38
+32.44%
|
0.29
|
| Asset Impairment Charge |
|
0.61
|
—
|
—
|
—
|
| Operating Gains Losses |
|
-0.00
+99.91%
|
-0.29
-684.67%
|
-0.04
+96.23%
|
-0.98
|
| Gain Loss On Investment Securities |
|
—
|
-0.29
-684.67%
|
-0.04
+96.23%
|
-0.98
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.00
|
—
|
—
|
—
|
| Change In Working Capital |
|
0.19
-64.97%
|
0.54
+141.64%
|
-1.30
-363.45%
|
0.49
|
| Change In Prepaid Assets |
|
-0.80
-609.71%
|
-0.11
-326.51%
|
0.05
-49.26%
|
0.10
|
| Change In Payables And Accrued Expense |
|
1.86
+40.61%
|
1.32
+273.99%
|
-0.76
-210.47%
|
0.69
|
| Change In Accrued Expense |
|
-0.41
-1016.70%
|
0.04
+106.39%
|
-0.69
-245.19%
|
0.48
|
| Change In Payable |
|
2.27
+77.13%
|
1.28
+1963.07%
|
-0.07
-132.40%
|
0.21
|
| Change In Account Payable |
|
1.93
+50.72%
|
1.28
+1963.07%
|
-0.07
-132.40%
|
0.21
|
| Change In Other Current Liabilities |
|
-0.88
-30.34%
|
-0.67
-14.89%
|
-0.59
-98.63%
|
-0.29
|
| Investing Cash Flow |
|
0.50
|
—
|
-0.69
-13.33%
|
-0.61
|
| Cash Flow From Continuing Investing Activities |
|
0.50
|
—
|
-0.69
-13.33%
|
-0.61
|
| Net PPE Purchase And Sale |
|
—
|
—
|
-0.69
-13.33%
|
-0.61
|
| Purchase Of PPE |
|
—
|
—
|
-0.69
-13.33%
|
-0.61
|
| Capital Expenditure |
|
—
|
—
|
-0.69
-13.33%
|
-0.61
|
| Net Investment Purchase And Sale |
|
0.50
|
—
|
—
|
—
|
| Sale Of Investment |
|
0.50
|
—
|
—
|
—
|
| Financing Cash Flow |
|
13.92
+2334.16%
|
0.57
+10063.16%
|
0.01
-90.66%
|
0.06
|
| Cash Flow From Continuing Financing Activities |
|
13.92
+2334.16%
|
0.57
+10063.16%
|
0.01
-90.66%
|
0.06
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
0.61
|
—
|
—
|
| Issuance Of Debt |
|
0.00
-100.00%
|
0.61
|
—
|
—
|
| Repayment Of Debt |
|
0.00
|
—
|
—
|
—
|
| Long Term Debt Issuance |
|
—
|
0.61
|
—
|
—
|
| Long Term Debt Payments |
|
0.00
|
—
|
—
|
—
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
0.61
|
—
|
—
|
| Short Term Debt Issuance |
|
0.00
|
0.00
|
—
|
—
|
| Short Term Debt Payments |
|
0.00
|
—
|
—
|
—
|
| Net Short Term Debt Issuance |
|
0.00
|
0.00
|
—
|
—
|
| Net Common Stock Issuance |
|
0.59
|
—
|
—
|
—
|
| Repurchase Of Capital Stock |
|
-0.40
|
—
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
9.34
+161899.22%
|
0.01
+2.51%
|
0.01
-90.66%
|
0.06
|
| Net Other Financing Charges |
|
-0.11
-168.12%
|
-0.04
|
—
|
—
|
| Changes In Cash |
|
-1.66
+68.10%
|
-5.22
+57.91%
|
-12.40
-16.45%
|
-10.65
|
| Beginning Cash Position |
|
3.33
-51.21%
|
6.82
-64.51%
|
19.22
-35.65%
|
29.86
|
| End Cash Position |
|
1.66
+3.82%
|
1.60
-76.52%
|
6.82
-64.51%
|
19.22
|
| Free Cash Flow |
|
-16.08
-177.73%
|
-5.79
+53.32%
|
-12.40
-15.85%
|
-10.71
|
| Common Stock Issuance |
|
0.59
|
—
|
—
|
—
|
| Issuance Of Capital Stock |
|
5.08
|
0.00
|
—
|
—
|
| Net Preferred Stock Issuance |
|
4.09
|
0.00
|
—
|
—
|
| Preferred Stock Issuance |
|
4.49
|
0.00
|
—
|
—
|
| Preferred Stock Payments |
|
-0.40
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-21 View
- 10-K2026-04-15 View
- 8-K2026-04-14 View
- 8-K2026-03-11 View
- 8-K2026-02-13 View
- 8-K2026-02-04 View
- 8-K2026-02-03 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 8-K2026-01-07 View
- 8-K2025-12-19 View
- 8-K2025-12-02 View
- 10-Q2025-11-19 View
- 8-K2025-10-30 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|